| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.22 | 5e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.008 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.14 | 0.01 |